BNET Industries

Pfizer Inc.

(PFE) is in the Pharma Industry

Market Cap:$140.6B

Last Fiscal Year Sales:$48.4B

Public
US

Dow Jones Description

Taking care of you and your four-legged friends too! Pfizer Inc. (NYSE: PFE), based in New York, NY, discovers, develops, manufactures and sells prescription medications for humans and animals. Employing about 115,000 people, this $51.3 billion company operates in three segments: Human Health, Consumer Healthcare and Animal Health. Together, these segments cover treatments for diseases such as cardiovascular and metabolic diseases, medications for oral care, tobacco dependence, and products for prevention and treatment of diseases in livestock and pets.

Number of Employees 81,800

Contact Information

235 E 42nd St

New York, New York 10017-5755

www.pfizer.com

(212) 573-2323

Peer Companies

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

Company News

Recent Events

Monsanto To Acquire Pfizer's Chesterfield Village Research Center - Quick Facts

11/09/09 - Merger / Acquisition - View Story
Monsanto To Acquire Pfizer's Chesterfield Village Research Center For $435 Mln. - Update

11/09/09 - Joint Venture / Alliance - View Story
Pfizer slashing 600 jobs from its St. Louis area work force

11/09/09 - Merger / Acquisition - View Story
UPDATE: Abbott Labs: US Justice Department Probing Depakote

11/06/09 - Legal Settlement - View Story
Trubion loses $6.2 million in Q3

11/05/09 - Joint Venture / Alliance - View Story
Pfizer extends Ligand research collaboration

11/09/09 - Joint Venture / Alliance - View Story
Generics Makers Line Up To Sell Copies Of Pfizer's Lipitor

11/06/09 - Financial Announcement - View Story
ViiV Healthcare launches: A new specialist HIV company dedicated to delivering advances in HIV treatment...

11/04/09 - Joint Venture / Alliance - View Story
xtremepicks.com: www.Xtremepicks.Com: Xtremepicks Alerts November 4, 2009 : FLML, XING, AFFY and MOCO

11/05/09 - Joint Venture / Alliance - View Story
Pfizer unveils its new Poultry Health division

11/03/09 - Product Announcement - View Story
Pfizer reportedly considers buying Protalix

11/03/09 - Merger / Acquisition - View Story
Pfizer, GSK launch HIV drug company

11/03/09 - Joint Venture / Alliance - View Story
Pfizer eyes deal with Israel's Protalix-newspaper

11/02/09 - Joint Venture / Alliance - View Story
Report: Pfizer may make a bid for Protalix

11/02/09 - Merger / Acquisition - View Story
Wockhardt says no plans to divest biotech biz

10/29/09 - Merger / Acquisition - View Story
Pfizer Is Ordered to Pay $850,000 to Brigham Young U. for Delaying Patent Litigation

10/28/09 - Lawsuit Filed - View Story
Pfizer leaders get $2.2 million in bonuses

10/29/09 - Merger / Acquisition - View Story
AstraZeneca Settles Seroquel Probe

10/30/09 - Legal Settlement - View Story
Pfizer Slashes Research, Staff after Wyeth Deal

11/09/09 - Merger / Acquisition - View Story
Pfizer sues Unilab over Lipitor drug

10/24/09 - Lawsuit Filed - View Story

News & Analysis

license agreement and pfizer inc. - All News and Analysis

Helsinn and Pfizer Laboratories (Pty) Ltd Sign a License Agreement for the Marketing of Aloxi(R) in South Africa.

- 2006-03-10

LUGANO, Switzerland and JOHANNESBURG, South Africa, March 10 /PRNewswire/ -- Helsinn Healthcare SA, and Pfizer Laboratories Pty Ltd, announce the signing of an agreement granting Pfizer in South Africa, the exclusive license and distribution ri LUGANO, Switzerland and JOHANNESBURG, South Africa, March...

Tags: license agreement, marketing, Pfizer Inc.
Incyte to Host Conference Call Today to Discuss Collaborative Research and License Agreement with Pfizer for the Development and Commercialization of CCR2 Antagonists; Conference Call is Scheduled to Begin at 8:30 a.m. ET Today

- 2005-11-21

WILMINGTON, Del. -- Incyte Corporation (Nasdaq:INCY) announced that it will host a conference call at 8:30 am ET today to discuss its collaborative research and license agreement with Pfizer for the development and commercialization of CCR2 antagonists. A copy of the press release, also released today, can be accessed at...

Tags: license agreement, Pfizer Inc.
Pfizer and Incyte Enter Collaborative Research and License Agreement for the Development and Commercialization of CCR2 Antagonists

- 2005-11-21

NEW YORK & WILMINGTON, Del. -- Incyte Corporation (NASDAQ:INCY):

Tags: license agreement, Pfizer Inc.
Pfizer Inc. (Active Pharmaceutical Ingredient Watch).(seeks to terminate license agreement with Novo Nordisk )(Brief Article)

- 2003-06-09

NOVO NORDISK A/S reports that Pfizer Inc. has attempted to terminate the license agreement under which Pfizer markets Novo Nordisk's portfolio of hormone replacement therapy products, Activella and Vagifem, in the US. In 2002, Novo Nordisk gained a NOVO NORDISK A/S reports that Pfizer...

Tags: license agreement, Pfizer Inc.
Inhale Therapeutic Systems and Pfizer Inc Enter Into Pulmonary Insulin Product Development and License Agreement

- 1995-01-19

PALO ALTO, Calif.--HealthWire--Jan. 19, 1995--Inhale Therapeutic Systems (Nasdaq:INHL) announced today that it has signed an agreement with Pfizer Inc (NYSE:PFE) to collaborate on the development of insulin products using Inhale's non-invasive pulmonary drug delivery system for macromolecules.

Tags: license agreement, Pfizer Inc.